Belgium· BE-AMP-SAM663434-00
Akantior 0.8 mg/ml
A polihexanide product containing polihexanide, registered in Belgium by SIFI. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Polihexanide is registered in 9 of 19 countries.
Countries holding a registration under ATC S01AX24 (polihexanide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Polihexanide · ATC S01AX24
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Polihexanide
- Manufacturer
- SIFI
- Country
- Belgium (BE)
- ATC code
- S01AX24
- ATC class
- Polihexanide
- Defined daily dose
- 4 Eindosisbeh
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polihexanide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKANTIORSIFI S.P.A., ACI SANT'ANTONIO (CT)
- FinlandAKANTIORSIFI S.p.A. Via Ercole Patti, 36
- IrelandAKANTIOR 0.8 mg/mL eye drops, solution in single-dose containerSIFI S.p.A.
- IcelandAKANTIORSIFI S.p.A.
- NetherlandsAKANTIOR 0,8 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikSIFI SpA
- SwedenAKANTIOR 0,8 mg/ml Ögondroppar, lösning i endosbehållareSIFI S.p.A.
- United KingdomAkantior 0.08% eye drops 0.3ml unit doseImported (Italy)
- SwitzerlandLavasept, gebrauchsfertige VerdünnungB. Braun Medical AG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Akantior
- Norway · Akantior
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8da796a9-9666-489e-b91d-7ea5f3a0d80c GET /v1/drugs/8da796a9-9666-489e-b91d-7ea5f3a0d80c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution in single-dose container",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Akantior 0.8 mg/ml",
"name_fr": "Akantior 0.8 mg/ml",
"name_nl": "Akantior 0.8 mg/ml",
"amp_code": "SAM663434-00",
"strengths": [
"0.8000",
"0.8000"
],
"pack_count": 3,
"substances": [
"Polihexanide",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Polihexanide",
"authorisation_numbers": [
"EU/1/24/1840/003",
"EU/1/24/1840/001",
"EU/1/24/1840/002"
]
}See everything about polihexanide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.